Navigation Links
Dr. Iffath Abbasi Hoskins Joins Americord's Advisory Board
Date:7/15/2014

NEW YORK, July 15, 2014 /PRNewswire/ -- Americord announced today that Iffath Abbasi Hoskins, M.D. has joined the company's Advisory Board. Dr. Hoskins is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at NYU Langone Medical Center in New York City. She is a practicing obstetrician-gynecologist and a sub-specialist in maternal-fetal medicine, which focuses on high-risk and complicated pregnancies.

"We are so pleased that Dr. Hoskins has agreed to join Americord's Advisory Board," said Americord CEO Martin Smithmyer. "She brings a wealth of experience in pregnancy and childbirth that is valuable to us as we pursue innovative technologies in the field of cord blood banking." Americord's Executive Medical Director, Dr. Robert Dracker, a highly regarded stem cell banking leader, and Dr. Eric Adler, a specialist in cardiovascular medicine who has done extensive research in the field of stem cells, are also members of the Advisory Board.

Dr. Hoskins and her colleagues are currently involved in investigations in areas pertaining to maternal and fetal well being, including antepartum fetal heart rate testing, fetal ultrasonography, maternal screening, obstetrical surgical techniques, maternal acid base status, and obstetrical complications including placenta previa. She is also involved in an ongoing investigation in the area of the pathogenesis and diagnosis of chorioamnionitis. Specifically, studying leukocyte and other esterases' activity for the diagnosis of this infection, the long-term goal being to develop a rapid simple, reliable assay for detecting chorioamnionitis in pregnancy and labor.

Dr. Hoskins has co-authored numerous scientific articles on pregnancy and childbirth for various medical publications. Dr. Hoskins earned her medical degree from Dow Medical College in Pakistan.

About Americord Registry Americord is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company's laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord's website at cordadvantage.com for more information. You may also find Americord on Facebook and follow the company on Twitter.Contact: Andrew FlookAmericord Registry866-503-6005andrew.flook@cordadvantage.com


'/>"/>
SOURCE Americord Registry
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Yale Cancer Center Joins OncLive's Strategic Alliance Partnership
2. Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff
3. Todd Rider Joins Draper to Continue Antiviral Therapeutics Development
4. Jesper Bramming, former A.P. Moller Executive, Joins the CMC Biologics Executive Management Team as Chief Financial Officer
5. Dr. Daniel Von Hoff Joins Lixte Biotechnologys Scientific Advisory Board
6. Bioentrepreneurship Leader Joins UM Ventures Team
7. Anthony A. Charity Joins Tunnell Consulting
8. CHI Joins More Than 30 State Life Sciences Associations in Urging Budget Conferees to Fix FDA User Fee Sequester
9. Craig Peloquin Joins Glissandra Skin Care as VP of Sales and Marketing
10. General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix Board Industry veteran and authority on patent law and valuation joins Spherix as director
11. Dr. Ungerleider Joins Forces with Childhelp
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... announced today that they have entered into a multiyear collaboration to identify and ... researchers with additional tools for gene editing across all applications. , Under the ...
(Date:10/12/2017)... ... 12, 2017 , ... AMRI, a global contract research, development ... patient outcomes and quality of life, will now be offering its impurity solutions ... new regulatory requirements for all new drug products, including the finalization of ICH ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
Breaking Biology Technology:
(Date:5/6/2017)... , May 5, 2017 ... just announced a new breakthrough in biometric authentication ... exploits quantum mechanical properties to perform biometric authentication. These ... smart semiconductor material created by Ram Group and ... finance, entertainment, transportation, supply chains and security. Ram ...
(Date:4/17/2017)... 17, 2017 NXT-ID, Inc. (NASDAQ: NXTD ... filing of its 2016 Annual Report on Form 10-K on Thursday ... ... available in the Investor Relations section of the Company,s website at ... website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... Research and Markets has announced the addition ... their offering. ... tracking market to grow at a CAGR of 30.37% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
Breaking Biology News(10 mins):